Candel Therapeutics (NASDAQ:CADL) is advancing two off-the-shelf viral immunotherapy candidates designed for local ...

TriKE® remains ongoing, with an update anticipated in 2H 2026Phase 1 basket trial evaluating GTB-5550 TriKE® in ...

President Donald Trump is ordering the U.S. Navy to remove the advanced system used to launch fighter jets from its newest ...

For 51-year-old Ingabire, what began as a recurring lump in her right breast eventually led to a cancer diagnosis and treatment at the University Teaching Hospital of Butare (CHUB). When the lump ...

According to St. Joseph’s Health, Pluvicto is an FDA-approved radioligand therapy for patients with PSMA-positive metastatic ...

Three decades after UC San Francisco pioneered "active surveillance" for patients with low-risk prostate cancer, a new study has found that the vast majority of veterans with the diagnosis pursued ...

As focal therapy gains popularity as a less invasive treatment option for some men with prostate cancer, a national study led by researchers at the University of Pittsburgh found that some men may be ...

Planning to submit a Biologics License Application (BLA) for aglatimagene besadenovec (aglatimagene) in localized, intermediate- to high-risk ...

Operator: Hello and welcome to Vir Biotechnology's Second Quarter 2026 Financial Results and Corporate Update Conference Call ...

Students in RISE spend 8 weeks working with a faculty mentor on their research project. This year, we were delighted to host ...

This eBook explores the latest advances in reproductive health research, covering fertility decline, endometriosis diagnostics, fetal therapies, environmental risks, male contraceptives, and ovarian ...